Total Funding
65
60
Total FundingDebt Financing raised
Growth Score
-5 pts
Heat Score
-15 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
74761
Affibody is a Swedish biotech company focused on developing products for therapy, diagnostic imaging, and other applications.
- Peter Zerhouni: Chief Financial Officer and Chief Business OfficerPast Role: InDex Pharmaceuticals, Chief Executive Officer
About the Company
Affibody is a Swedish biotech company focused on developing next generation products for therapy, diagnostic imaging, and other applications based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.
Affibody® molecules, which are small, robust and easily produced, can be designed to bind specifically to a large
number of target proteins. They have a broad range of applications including protein purification, enzyme inhibition, research reagents for protein capture and detection, diagnostics, including molecular imaging, and targeted therapeutics.
